MEDISTIM ASA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 180 NOK | +2.86% |
|
+2.27% | -15.89% |
| Apr. 25 | Transcript : Medistim ASA, Q1 2024 Earnings Call, Apr 25, 2024 | |
| Apr. 24 | Medistim ASA Approves Dividend for the Year 2023, Payable on May 6, 2024 | CI |
Presenter SpeechKari Krogstad (Executives)Okay. Good morning, everybody, and welcome to Medist...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Medistim ASA is a Norway-based company engaged in the provision of medical equipment and technology. It develops, manufactures and distributes medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the outcome of cardiac and vascular surgery. The Company provides Transit Time Flow Measurement (TTFM) and ultrasound imaging to the global market to enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery. Medistimâs activities are divided into two business units: Own Products Category and Third-Party Products Category. Furthermore, the Company has several subsidiaries, including Medistim USA Inc, Medistim Norge AS and Medistim Japan KK.
Calendar
2024-08-15
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
180
NOK
Average target price
190
NOK
Spread / Average Target
+5.56%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -15.89% | 290M | |
| +8.69% | 219B | |
| +6.69% | 183B | |
| +10.90% | 133B | |
| +25.41% | 108B | |
| +0.27% | 63.06B | |
| +12.72% | 52.02B | |
| +3.96% | 48.2B | |
| +0.40% | 40.37B | |
| +15.03% | 39.35B |
- Stock Market
- Equities
- MEDI Stock
- News Medistim ASA
- Transcript : Medistim ASA, Q3 2023 Earnings Call, Oct 27, 2023
